S&P 500   5,123.11 (-1.46%)
DOW   37,979.50 (-1.25%)
QQQ   438.46 (-1.55%)
AAPL   176.47 (+0.82%)
MSFT   421.94 (-1.40%)
META   512.20 (-2.09%)
GOOGL   157.70 (-1.07%)
AMZN   185.82 (-1.71%)
TSLA   171.27 (-1.91%)
NVDA   882.42 (-2.62%)
AMD   163.65 (-4.02%)
NIO   4.13 (-7.40%)
BABA   71.54 (-4.42%)
T   16.28 (-0.85%)
F   12.55 (-3.76%)
MU   122.68 (-3.79%)
GE   154.51 (-1.84%)
CGC   7.77 (-4.66%)
DIS   114.14 (-2.57%)
AMC   2.65 (-5.36%)
PFE   25.91 (-1.63%)
PYPL   64.57 (-1.87%)
XOM   120.12 (-1.37%)
S&P 500   5,123.11 (-1.46%)
DOW   37,979.50 (-1.25%)
QQQ   438.46 (-1.55%)
AAPL   176.47 (+0.82%)
MSFT   421.94 (-1.40%)
META   512.20 (-2.09%)
GOOGL   157.70 (-1.07%)
AMZN   185.82 (-1.71%)
TSLA   171.27 (-1.91%)
NVDA   882.42 (-2.62%)
AMD   163.65 (-4.02%)
NIO   4.13 (-7.40%)
BABA   71.54 (-4.42%)
T   16.28 (-0.85%)
F   12.55 (-3.76%)
MU   122.68 (-3.79%)
GE   154.51 (-1.84%)
CGC   7.77 (-4.66%)
DIS   114.14 (-2.57%)
AMC   2.65 (-5.36%)
PFE   25.91 (-1.63%)
PYPL   64.57 (-1.87%)
XOM   120.12 (-1.37%)
S&P 500   5,123.11 (-1.46%)
DOW   37,979.50 (-1.25%)
QQQ   438.46 (-1.55%)
AAPL   176.47 (+0.82%)
MSFT   421.94 (-1.40%)
META   512.20 (-2.09%)
GOOGL   157.70 (-1.07%)
AMZN   185.82 (-1.71%)
TSLA   171.27 (-1.91%)
NVDA   882.42 (-2.62%)
AMD   163.65 (-4.02%)
NIO   4.13 (-7.40%)
BABA   71.54 (-4.42%)
T   16.28 (-0.85%)
F   12.55 (-3.76%)
MU   122.68 (-3.79%)
GE   154.51 (-1.84%)
CGC   7.77 (-4.66%)
DIS   114.14 (-2.57%)
AMC   2.65 (-5.36%)
PFE   25.91 (-1.63%)
PYPL   64.57 (-1.87%)
XOM   120.12 (-1.37%)
S&P 500   5,123.11 (-1.46%)
DOW   37,979.50 (-1.25%)
QQQ   438.46 (-1.55%)
AAPL   176.47 (+0.82%)
MSFT   421.94 (-1.40%)
META   512.20 (-2.09%)
GOOGL   157.70 (-1.07%)
AMZN   185.82 (-1.71%)
TSLA   171.27 (-1.91%)
NVDA   882.42 (-2.62%)
AMD   163.65 (-4.02%)
NIO   4.13 (-7.40%)
BABA   71.54 (-4.42%)
T   16.28 (-0.85%)
F   12.55 (-3.76%)
MU   122.68 (-3.79%)
GE   154.51 (-1.84%)
CGC   7.77 (-4.66%)
DIS   114.14 (-2.57%)
AMC   2.65 (-5.36%)
PFE   25.91 (-1.63%)
PYPL   64.57 (-1.87%)
XOM   120.12 (-1.37%)

Windtree Therapeutics (WINT) News Today

$0.42
+0.04 (+10.29%)
(As of 03:50 PM ET)
SourceHeadline
finanznachrichten.de logoWindtree Therapeutics: Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
finanznachrichten.de - April 9 at 8:09 AM
globenewswire.com logoWindtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
globenewswire.com - April 8 at 4:48 PM
msn.com logoWindtree Therapeutics Seeks Strategic Alternatives with Ladenburg Thalmann
msn.com - February 2 at 1:10 AM
finance.yahoo.com logoWindtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
finance.yahoo.com - February 1 at 10:09 AM
bizjournals.com logoWindtree Therapeutics hires investment bank to explore M&A options
bizjournals.com - January 31 at 1:46 PM
finance.yahoo.com logoWindtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
finance.yahoo.com - January 31 at 1:46 PM
benzinga.com logoWindtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
benzinga.com - January 29 at 1:53 PM
finanznachrichten.de logoWindtree Therapeutics Eliminates $15 Million Contingent Liability To Deerfield Management Company
finanznachrichten.de - January 26 at 7:18 PM
finance.yahoo.com logoWindtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
finance.yahoo.com - January 26 at 7:18 PM
benzinga.com logoWindtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
benzinga.com - January 25 at 12:19 PM
finance.yahoo.com logoWindtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
finance.yahoo.com - January 25 at 12:19 PM
money.usnews.com logoWindtree Therapeutics Inc
money.usnews.com - January 24 at 12:22 AM
msn.com logoWindtree and Lee’s sign licence deal for heart failure therapy
msn.com - January 18 at 3:29 PM
finance.yahoo.com logoUp To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
finance.yahoo.com - January 18 at 10:28 AM
bizjournals.com logoWindtree Therapeutics signs drug licensing deal valued at up to $138M with Chinese drug company
bizjournals.com - January 17 at 6:16 PM
finance.yahoo.com logoWindtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region
finance.yahoo.com - January 17 at 8:16 AM
markets.businessinsider.com logoHold Rating on Windtree Therapeutics Pending Key Istaroxime Studies
markets.businessinsider.com - January 4 at 12:13 AM
msn.com logoHC Wainwright & Co. Initiates Coverage of Windtree Therapeutics (WINT) with Neutral Recommendation
msn.com - January 3 at 7:12 PM
markets.businessinsider.com logoWindtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
markets.businessinsider.com - January 2 at 7:16 PM
finance.yahoo.com logoWindtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
finance.yahoo.com - January 2 at 7:16 PM
finance.yahoo.com logoIstaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024
finance.yahoo.com - December 19 at 12:07 PM
finance.yahoo.com logoWindtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock
finance.yahoo.com - December 18 at 9:44 AM
finance.yahoo.com logoWindtree Therapeutics Announces Issuance of New Pure SERCA2a Activator Patent
finance.yahoo.com - November 16 at 8:08 AM
msn.com logoWindtree TherapeuticS GAAP EPS of -$0.86
msn.com - November 9 at 10:58 PM
finance.yahoo.com logoWindtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
finance.yahoo.com - November 9 at 5:57 PM
finance.yahoo.com logoWindtree to Present at the Sidoti Micro Cap Conference on November 16th
finance.yahoo.com - November 8 at 10:47 AM
tmcnet.com logoWindtree to Present at the ThinkEquity Conference on October 19th in New York City
tmcnet.com - October 12 at 8:00 AM
finance.yahoo.com logoWindtree to Present at the ThinkEquity Conference on October 19th in New York City
finance.yahoo.com - October 12 at 8:00 AM
finance.yahoo.com logoWindtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th
finance.yahoo.com - October 10 at 9:56 AM
finance.yahoo.com logoWindtree to Present at the Dawson James Small Cap Growth Conference on October 12th
finance.yahoo.com - October 3 at 10:32 AM
markets.businessinsider.com logoWindtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office
markets.businessinsider.com - August 23 at 8:28 AM
finance.yahoo.com logoWindtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office
finance.yahoo.com - August 23 at 8:28 AM
finance.yahoo.com logoWindtree Therapeutics (NASDAQ:WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
finance.yahoo.com - August 16 at 5:43 PM
benzinga.com logoHow Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators
benzinga.com - August 15 at 5:22 PM
benzinga.com logoWindtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
benzinga.com - August 15 at 5:22 PM
finance.yahoo.com logoWindtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
finance.yahoo.com - August 8 at 9:18 AM
finance.yahoo.com logoWindtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
finance.yahoo.com - July 25 at 12:52 PM
finance.yahoo.com logoThe Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
finance.yahoo.com - July 18 at 12:31 PM
benzinga.com logoWindtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis
benzinga.com - July 14 at 12:05 PM
finance.yahoo.com logoMedical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ:WINT) Is Helping Change That
finance.yahoo.com - July 14 at 12:04 PM
benzinga.com logoMedical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
benzinga.com - July 12 at 1:15 PM
msn.com logoWindtree Therapeutics (WINT) Price Target Decreased by 47.37% to 5.10
msn.com - July 7 at 12:24 AM
finance.yahoo.com logoWindtree Therapeutics Appoints Mark Strobeck, Ph.D. to Board of Directors
finance.yahoo.com - June 27 at 10:09 AM
finance.yahoo.com logoWindtree Therapeutics Appoints Mark Strobeck, Ph.D. to Board of Directors
finance.yahoo.com - June 27 at 10:09 AM
finance.yahoo.com logoWindtree Announces Notice of Allowance from the US Patent and Trademark Office for a Group of SERCA2a Activators with a Dual Mechanism
finance.yahoo.com - June 12 at 6:43 PM
finance.yahoo.com logoWindtree Therapeutics to Host Virtual R&D and Investor Day Focusing on the Cardiogenic Shock Market, Istaroxime, Company Strategy and Planned Near-Term Milestones
finance.yahoo.com - June 5 at 11:10 AM
finance.yahoo.com logoWindtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
finance.yahoo.com - May 15 at 7:02 PM
finance.yahoo.com logoWindtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
finance.yahoo.com - May 15 at 7:02 PM
finance.yahoo.com logoWindtree Therapeutics Announces Publication from Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime
finance.yahoo.com - April 27 at 10:00 AM
finance.yahoo.com logoWindtree Therapeutics Announces Closing of $12.42 Million Underwritten Public Offering Including Full Exercise of Overallotment Option
finance.yahoo.com - April 24 at 4:13 PM
Get Windtree Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter.

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

WINT Media Mentions By Week

WINT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

WINT
News Sentiment

0.38

0.61

Average
Medical
News Sentiment

WINT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

WINT Articles
This Week

4

1

WINT Articles
Average Week

Get Windtree Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:WINT) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners